{"log_id": 3644142885182741622, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0.007866, "average": 0.976682, "min": 0.424915}, "location": {"width": 1098, "top": 294, "height": 47, "left": 233}, "words": "建议暂停用药,同时监测血清转氨酶及总胆红素直至其水平明显下降后可恢复用药;如恢复"}, {"probability": {"variance": 0.008841, "average": 0.972975, "min": 0.412432}, "location": {"width": 1096, "top": 338, "height": 50, "left": 233}, "words": "用药后再次出现34级不良反应,可下调一个剂量后继续用药(参见【用法用量】)如不良"}, {"probability": {"variance": 8e-06, "average": 0.998151, "min": 0.989998}, "location": {"width": 271, "top": 388, "height": 31, "left": 235}, "words": "反应仍持续,建议停药"}, {"probability": {"variance": 2.2e-05, "average": 0.997163, "min": 0.986761}, "location": {"width": 159, "top": 461, "height": 31, "left": 237}, "words": "一般注意事项"}, {"probability": {"variance": 0.000537, "average": 0.989541, "min": 0.88059}, "location": {"width": 1037, "top": 500, "height": 45, "left": 285}, "words": "血压升高:血压升高是 VEGFR抑制剂类抗肿瘤药物最常见的不良反应之一临床研究中"}, {"probability": {"variance": 0.006375, "average": 0.976637, "min": 0.612548}, "location": {"width": 1092, "top": 541, "height": 45, "left": 233}, "words": "观察到服用阿帕替尼可引起血压升高,一般为轻到中度,多在服药后2周左右出现,常規的降"}, {"probability": {"variance": 0.003935, "average": 0.985026, "min": 0.591399}, "location": {"width": 1092, "top": 582, "height": 41, "left": 233}, "words": "压药物一般可以控制。服药期间应常规监测血压的变化,如有需要应在专科医师指导下进行降"}, {"probability": {"variance": 0.01346, "average": 0.963211, "min": 0.358929}, "location": {"width": 1089, "top": 619, "height": 52, "left": 233}, "words": "压治疗或调整本品剂量如发生34级血压升高,建议暂停用药;如恢复用药后再次出现3/4"}, {"probability": {"variance": 0.001856, "average": 0.98474, "min": 0.737879}, "location": {"width": 1092, "top": 662, "height": 47, "left": 230}, "words": "级血压升高,可下调一个剂量后继续用药(参见【用法用量】),如不良反应仍持续,建议停"}, {"probability": {"variance": 0.000271, "average": 0.991496, "min": 0.929045}, "location": {"width": 593, "top": 703, "height": 36, "left": 233}, "words": "药。对于高血压危象的患者,发生期间应停用本品"}, {"probability": {"variance": 0.00554, "average": 0.975102, "min": 0.595968}, "location": {"width": 1039, "top": 742, "height": 45, "left": 283}, "words": "蛋白尿:蛋白尿是 VEGFR抑钊剂类抗肿瘤药物最常见的不良反应之一。临床研究中观察"}, {"probability": {"variance": 0.001607, "average": 0.979246, "min": 0.840076}, "location": {"width": 1092, "top": 783, "height": 38, "left": 230}, "words": "到服用阿帕替尼可引起蛋白尿,当用于肾功能不全患者时应谨慎和密切监测。建议患者定期检"}, {"probability": {"variance": 0.001508, "average": 0.986002, "min": 0.768379}, "location": {"width": 1080, "top": 817, "height": 52, "left": 230}, "words": "查尿常规,在用药的最初两个月内应定期例如每2周检查1次尿常规,之后每4周检查1次"}, {"probability": {"variance": 0.001048, "average": 0.984707, "min": 0.852108}, "location": {"width": 1089, "top": 858, "height": 50, "left": 230}, "words": "发生蛋白尿时请及时就医。如发生≥2级的蛋白尿,建议暂停用药;如恢复用药后再次出现≥"}, {"probability": {"variance": 0.013534, "average": 0.967364, "min": 0.366671}, "location": {"width": 1092, "top": 900, "height": 45, "left": 228}, "words": "2级的蛋白尿,可下调一个剂量后续用药(参见【用法用量】),如不良反应仍持续,建议"}, {"probability": {"variance": 0, "average": 0.999876, "min": 0.999782}, "location": {"width": 59, "top": 941, "height": 31, "left": 230}, "words": "停药"}, {"probability": {"variance": 0.010568, "average": 0.966743, "min": 0.397742}, "location": {"width": 1034, "top": 977, "height": 45, "left": 285}, "words": "皮肤毒性手足综合征(手掌、足底红肿疼痛或指端红斑)是服用本品后最常见的皮肤不"}, {"probability": {"variance": 0.004398, "average": 0.980098, "min": 0.575305}, "location": {"width": 1089, "top": 1018, "height": 41, "left": 230}, "words": "良反应,通常为轻中度(1-2级)、1级手足综合征定义为出现下列任一现象:手和或足的麻"}, {"probability": {"variance": 0.003095, "average": 0.979173, "min": 0.738538}, "location": {"width": 1087, "top": 1057, "height": 38, "left": 233}, "words": "木、感觉迟钝感觉异常、麻刺、红斑和或不影响正常活动的不适;2级定义为手和足的"}, {"probability": {"variance": 0.022048, "average": 0.929787, "min": 0.372378}, "location": {"width": 1066, "top": 1096, "height": 43, "left": 228}, "words": "疼性红斑和肿胀和或影响患者日常工作的不适;3级定义为手和或足的湿性脱屑、溃疡"}, {"probability": {"variance": 0.010445, "average": 0.968652, "min": 0.427925}, "location": {"width": 1064, "top": 1135, "height": 45, "left": 228}, "words": "水或严重的疼痛和或使患者不能工作或进行日常工作的严重不适。如果发生手足综合征"}, {"probability": {"variance": 0.009424, "average": 0.96727, "min": 0.393868}, "location": {"width": 1089, "top": 1176, "height": 43, "left": 230}, "words": "可在医师指导下采取一些必要的对症支持治疗,包括:加强皮肤护理,保持皮肤清,避免继"}, {"probability": {"variance": 0.019865, "average": 0.929644, "min": 0.43575}, "location": {"width": 1092, "top": 1215, "height": 43, "left": 228}, "words": "发感染;避免压力摩擦:使用润肤霜戒润滑剂,部使用含尿素和皮质类固醇成分的乳液或"}, {"probability": {"variance": 0.015821, "average": 0.951123, "min": 0.387372}, "location": {"width": 1092, "top": 1251, "height": 47, "left": 228}, "words": "润滑剂;必要时局部使用抗真菌或抗生素治。如连续出现3次≥2级的手足综合征,且有加"}, {"probability": {"variance": 0.009462, "average": 0.961896, "min": 0.546474}, "location": {"width": 1092, "top": 1293, "height": 45, "left": 228}, "words": "重趋势的,建议暂停用药;如恢复用药后再次出现≥2级的手足综合征可下调一个剂量后缝"}, {"probability": {"variance": 0.000513, "average": 0.988192, "min": 0.906587}, "location": {"width": 728, "top": 1334, "height": 38, "left": 228}, "words": "续用药(参见【用法用量】):如不良反应仍持续,建议停药"}, {"probability": {"variance": 0.012935, "average": 0.954177, "min": 0.498297}, "location": {"width": 1039, "top": 1370, "height": 45, "left": 280}, "words": "腹泻:腹泻患者服用本晶可能会影响本品的吸收,故应积极治疗导致腹泻的疾病,好转后"}, {"probability": {"variance": 1.7e-05, "average": 0.996111, "min": 0.986042}, "location": {"width": 294, "top": 1414, "height": 34, "left": 230}, "words": "可在医师指导下服用本品"}, {"probability": {"variance": 0.002102, "average": 0.978151, "min": 0.816725}, "location": {"width": 1039, "top": 1457, "height": 43, "left": 278}, "words": "服用本品期间如发生34级腹泻,建议暂停用药;如恢复用药后再次出现34级腹泻,可"}, {"probability": {"variance": 0.006185, "average": 0.97218, "min": 0.53356}, "location": {"width": 936, "top": 1503, "height": 36, "left": 230}, "words": "下调一个剂量后继续用药(参见【用法用量】),如不良反应仍持续,建议停药"}, {"probability": {"variance": 0.020118, "average": 0.946048, "min": 0.366343}, "location": {"width": 1037, "top": 1546, "height": 41, "left": 283}, "words": "伤口愈合并发症:未进行服用阿帕尼对伤口愈合影响的专门研究。在阿帕替尼临床研究"}, {"probability": {"variance": 0.006828, "average": 0.96723, "min": 0.646784}, "location": {"width": 1085, "top": 1590, "height": 38, "left": 230}, "words": "中排除了4周内进行过大手术伤口未愈合的患者。鉴于手术后息者何时再服用阿帕替尼的经验"}, {"probability": {"variance": 0.006858, "average": 0.974086, "min": 0.5962}, "location": {"width": 683, "top": 1635, "height": 34, "left": 228}, "words": "有限,建议手术前及手术后的30天内,誓时停止服用本品"}, {"probability": {"variance": 0.006225, "average": 0.966376, "min": 0.617295}, "location": {"width": 1039, "top": 1692, "height": 45, "left": 280}, "words": "对驾驶及操纵机器能力的影响:在本品治疗期间:可能会出深乏力的症状,建议患者在驾"}, {"probability": {"variance": 0.031411, "average": 0.92371, "min": 0.374512}, "location": {"width": 326, "top": 1736, "height": 34, "left": 228}, "words": "驶或操机器时应予以注意"}, {"probability": {"variance": 0.021757, "average": 0.872695, "min": 0.636084}, "location": {"width": 111, "top": 1777, "height": 31, "left": 280}, "words": "患者须知"}], "language": -1}